September 3, 2009

Pfizer’s $2.3 Billion Settlement Leaves Victims in the lurch

The level of corruption that the pharmaceutical industry engages in–with assistance by prominent academic physicians who prostitute

Read More
Pfizer’s $2.3 Billion Settlement Leaves Victims in the lurch

August 18, 2009

Top FDA Officials, Compromised by Conflicts of Interest

Dr. Daniel Schultz, who has been FDA’s chief medical device official, is the first high ranking FDA

Read More
Top FDA Officials, Compromised by Conflicts of Interest

August 5, 2009

Ghosted Journal Articles Undermine Integrity of Medicine

For years we have disseminated reports documenting one after another uncovered case of corruption demonstrating that so-called

Read More
Ghosted Journal Articles Undermine Integrity of Medicine

July 25, 2009

ACRE–A High Powered Harvard Stealth Pharma Front Group

Daniel Carlat, MD , is Associate Clinical Professor of Psychiatry Tufts University School of Medicine Publisher and

Read More
ACRE–A High Powered Harvard Stealth Pharma Front Group

July 17, 2009

Is the Schizophrenia Mortality Study in The Lancet CREDIBLE?

A study purporting to analyze mortality rates of 66, 881 schizophrenia patients in Finland (1973 to 2005)

Read More
Is the Schizophrenia Mortality Study in The Lancet CREDIBLE?

June 17, 2009

Children Rx ADHD Drugs 7.4 times increased risk of sudden death

Empirical findings published in the American Journal of Psychiatry lend validity to the long debated claim by

Read More
Children Rx ADHD Drugs 7.4 times increased risk of sudden death

June 7, 2009

Is FDA Bipolar or Complicit in Legitimizing Illegal Marketing?

FDA officials are ignoring the real world tragedies–drug-induced deaths of children. Unfortunately for the children, child psychiatrists

Read More
Is FDA Bipolar or Complicit in Legitimizing Illegal Marketing?

June 4, 2009

Marketing Trumps Safety: the case of Antipsychotics

Just as the FDA is convening an advisory committee hearing (June 9-10) about whether to expand the

Read More
Marketing Trumps Safety: the case of Antipsychotics

June 3, 2009

USA Today: Conflicts of interest bedevil psychiatric drug research

Ever wondered how toxic psychoactive drugs that have been shown to be clinically insignificant have been catapulted

Read More
USA Today: Conflicts of interest bedevil psychiatric drug research

May 8, 2009

Has the Obama administration already cowered to the demands of Big Pharma?

The unexpected approval of a "me too" dangerous antipsychotic drug that the agency itself had deemed "NOT

Read More
Has the Obama administration already cowered to the demands of Big Pharma?

May 7, 2009

Title: FDA Approves Antipsychotic With Long History of Failure

"Hoechst Marion Roussel Inc. made initial inquiries into the drug; however, in May 1996, they discontinued research,

Read More
Title: FDA Approves Antipsychotic With Long History of Failure

May 6, 2009

NAMI Acknowledges: 56% of Budget Comes from Drug Companies

It’s time to set the record straight about NAMI: NAMI was founded about 25 years ago. It

Read More
NAMI Acknowledges: 56% of Budget Comes from Drug Companies

April 29, 2009

Institute of Medicine Calls for Doctors to Stop Taking Gifts From Drug Makers

If enacted, the IOM recommendations will essentially sever the financial ties that bind American medicine–its practitioners, researchers,

Read More
Institute of Medicine Calls for Doctors to Stop Taking Gifts From Drug Makers

April 21, 2009

Does the FDA have the authority to trump the Declaration of Helsinki?

An editorial by Dr. Michael Goodyear, of Dalhousie University (Canada), and a board member of The Alliance

Read More
Does the FDA have the authority to trump the Declaration of Helsinki?